Home

Company Profile

Shanghai Dynegene Technologies Co., Ltd.

Dynegene Technologies, established in Shanghai, China in 2018, is an innovative high-tech company in the rapidly developing field of synthetic biology, and the only enterprise that can commercialize ultra-high-throughput next-generation DNA synthesis in China. Dynegene has received hundreds of millions of yuan in investment from Volcanics Venture, Chaosheng Capital, MSA Capital, Boyu Capital, and ByteDance and other well-known domestic investment institutions. The company is committed to new generation of nucleic acid synthesis and provides strong support for the fields of synthetic biology, molecular diagnostic raw materials and biomedical tools. Dynegene Technologies has successfully developed a DYHOW Technology based ultra-high-throughput in situ DNA synthesis platform with independent intellectual property rights, achieving a breakthrough in this field in China. The throughput, accuracy rate, length and other related technical indicators of our products have reached world-class levels. At present, our high-quality products have gained the favor and recognition of numerous molecular diagnostic enterprises and customers from industries such as antibody drug screening, novel biomanufacturing and nucleic acid drugs.

  • 1st

    The first company in China engaged in next-generation DNA synthesis

  • 3rd

    The third commercialized company with similar technologies in the world

  • 9years

    cumulative technological platform innovation

  • 100

    Nearly one-hundred partners

  • 10,000m2

    Production base

Development History

2022

2021

2020

2019

2018

2017

  • October

    A commercial high-throughput DNA synthesis platform was first developed in China

  • September

    Finished Series A+ round financing

  • July

    Shanghai Jiao Tong University - Dynegene Technologies New Generation Nucleic Acid Synthesis Joint Research Center was established

2022

  • October

    Shanghai Dynegene Technologies Co., Ltd. relocated to a new laboratory office with an area of 2,000 square meters in the Minhang District of Shanghai

  • Dynegene Technologies received nearly 100 million yuan in Round A investment

2021

  • Successfully developed high-throughput automated gene synthesis platform based on cluster array

2020

  • Establishment of GMP Production Base in Qingpu Zhangjiang CloudCube Park

2019

  • The company finished angel round financing

  • Shanghai Dynegene Technologies Co., Ltd. was officially established

2018

  • September

    Wuxi Dynegene Technologies Co., Ltd. was founded and the first laboratory and production base was established

2017

Founding Team

Dynegene Next-Gen Synthesis: Powering Biotech Revolution With Nucleic Acids

Contact Us

Tel: 400-017-9077

Address: Floor 2, Building 5, No. 248 Guanghua Road, Minhang District, Shanghai

Email: zhengyuqing@dynegene.com

Follow Us

Copyright © 2024 Shanghai Dynegene Technologies Co., Ltd.
All rights reserved.   

Website Map I Privacy Policy